Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Nature

• Publication date

  1980-06-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/285417A0PMID 6892950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical study on gastric secretion with special reference to pepsin secretion

  2007cited by this paper
• Interaction of a newly isolated intestinal polypeptide (PHI) with glucose and arginine to effect the secretion of insulin and glucagon.

  1980cited by this paper
• Chemical determination of polypeptide hormones.

  1978cited by this paper
• The amino acid sequence of a hypothalamic peptide, neurotensin.

  1975cited by this paper
• Candidate hormones of the gut. VI. Bovine pancreatic polypeptide (BPP) and avian pancreatic polypeptide (APP).

  1974cited by this paper
• Atlas of protein sequence and structure

  1965cited by this paper

• The role of PYY in improving insulin resistance.

  2026influential citation
• Discovery of peptides as key regulators of metabolic and cardiovascular crosstalk

  2025cites this paper
• Neuropeptide Y at the crossroads of neurodegeneration: Mechanistic insights and emerging therapeutic strategies.

  2025cites this paper
• Gut Hormones and Inflammatory Bowel Disease

  2025cites this paper
• ProSAAS neuropeptides and receptors GPR171 and GPR83: Potential therapeutic applications for pain, anxiety, and body weight regulation.

  2025cites this paper
• Invited Review for the special issue of PEPTIDES, "A centennial tribute to Viktor Mutt".

  2025cites this paper
• Effects of physical form of β-lactoglobulin and calcium ingestion on GLP-1 secretion, gastric emptying and energy intake in humans: a randomised crossover trial

  2024influential citation
• Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects

  2024cites this paper
• Amylin‐like immunoreactivity in the extra‐islet peptide YY‐producing and glucagon‐immunoreactive cells in Japanese quail pancreas

  2024cites this paper
• Gastrointestinal hormones: History, biology, and measurement.

  2024cites this paper
• Origins, Technological Advancement, and Applications of Peptidomics.

  2024cites this paper
• The effects of gut microbiota on appetite regulation and the underlying mechanisms

  2024cites this paper
• Four decades of research on Viktor Mutt’s neuropeptides with focus on galanin

  2024cites this paper
• Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?

  2023cites this paper
• PYY (3-36) protects against high fat feeding induced changes of pancreatic islet and intestinal hormone content and morphometry.

  2023cites this paper
• History of key regulatory peptide systems and perspectives for future research

  2023influential citation
• Mass spectrometry in the discovery of peptides involved in intercellular communication: From targeted to untargeted peptidomics approaches.

  2022cites this paper
• Reviewed and updated Algorithm for Genetic Characterization of Syndromic Obesity Phenotypes

  2022cites this paper
• Peptide YY 3–36 attenuates trinitrobenzene sulfonic acid-induced colitis in mice by modulating Th1/Th2 differentiation

  2022cites this paper
• Peptide YY

  2021cites this paper
• Peptide histidine isoleucine/methionine

  2021cites this paper
• Pathogenesis of irritable bowel syndrome

  2020cites this paper
• A dynamic mouse peptidome landscape reveals probiotic modulation of the gut-brain axis

  2020cites this paper
• The Implication of Gut Hormones in the Regulation of Energy Homeostasis and Their Role in the Pathophysiology of Obesity

  2020cites this paper
• Leveraging the Gut to Treat Metabolic Disease.

  2020cites this paper
• Design and evaluation of fluorescent and non-fluorescent bivalent ligands to explore their mode of action at neuropeptide Y receptors

  2019cites this paper
• Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS).

  2019cites this paper
• Oxidative grafting vs. monolayers self-assembling on gold surface for the preparation of electrochemical immunosensors. Application to the determination of peptide YY.

  2019cites this paper
• Neuropeptide receptors as potential pharmacological targets for obesity

  2019cites this paper
• Role of Neuropeptide y in Endotoxemia

  2019cites this paper
• The metabolic sequelae of oesophago-gastric resection

  2019cites this paper
• Usefulness of antidiabetic alpha-glucosidase inhibitors: a review on the timing of administration and effects on gut hormones.

  2019cites this paper
• PYY is a negative regulator of bone mass and strength

  2019cites this paper
• Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness

  2018cites this paper
• Gastrointestinal Hormones Controlling Energy Homeostasis and Their Potential Role in Obesity

  2018cites this paper
• Neural Secretions and Regulation of Gut Functions

  2018cites this paper
• Structural and functional characterization of peptide YY on feeding in Schizothorax davidi.

  2018cites this paper
• Mapping molecular datasets back to the brain regions they are extracted from: Remembering the native countries of hypothalamic expatriates and refugees

  2018cites this paper
• Systems Neuroscience

  2018cites this paper
• Existing and prospective pathways for intervention in treatment of obesity in a novel way‒a review

  2018cites this paper
• Carboxypeptidase E and the Identification of Novel Neuropeptides as Potential Therapeutic Targets.

  2018cites this paper
• Islet neuropeptide Y receptors are functionally conserved and novel targets for the preservation of beta‐cell mass

  2018cites this paper
• Origins, Technological Development, and Applications of Peptidomics.

  2018cites this paper
• Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors

  2018cites this paper
• Chimeric peptide EP 45 as a dual agonist at GLP-1 and NPY 2 R receptors

  2018cites this paper
• 154 Exploiting the Gut to Treat Obesity

  2017cites this paper
• Peptide Tyrosine Tyrosine 3-36 Reduces Meal Size and Activates the Enteric Neurons in Male Sprague–Dawley Rats

  2017cites this paper
• Peptide YY (3-36) modulates intracellular calcium through activation of the phosphatidylinositol pathway in hippocampal neurons.

  2017cites this paper
• Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease

  2017cites this paper
• Short and Long Chain Free Fatty Acids Differentially Regulate Glucagon-like Peptide-1 and Peptide YY Transcript Levels in Enteroendocrine Cells (STC-1)

  2017cites this paper
• Central Modulation of Energy Homeostasis and Cognitive Performance After Bariatric Surgery.

  2017cites this paper
• Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival.

  2016cites this paper
• Human melanocortin-3 receptor: structure-function relationship of DPLIY motif and helix 8 and biased signaling

  2016cites this paper
• The role of gut hormones on food intake and carbohydrate tolerance

  2016cites this paper
• Subchapter 25C – Peptide YY

  2016cites this paper
• Solution Structure and Constrained Molecular Dynamics Study of Vitamin B12 Conjugates of the Anorectic Peptide PYY(3–36)

  2016cites this paper
• Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome.

  2016cites this paper
• The neuroendocrine genome : neuropeptides and related signaling peptides

  2016cites this paper
• Identification of a Cyanine-Dye Labeled Peptidic Ligand for Y1R and Y4R, Based upon the Neuropeptide Y C-Terminal Analogue, BVD-15.

  2016cites this paper
• Optically Pure, Structural, and Fluorescent Analogues of a Dimeric Y4 Receptor Agonist Derived by an Olefin Metathesis Approach.

  2016cites this paper
• Neuropeptide Y is an angiogenic factor in cardiovascular regeneration.

  2016cites this paper
• The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD).

  2016cites this paper
• Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome

  2016cites this paper
• Acute effects of exercise on appetite, appetite regulatory hormones and energy intake in lean and overweight men and women

  2016cites this paper
• Role of gastrointestinal hormones in feeding behavior and obesity treatment

  2016cites this paper
• The cumulative effects of seven days of imposed exercise on energy balance and appetite regulation

  2016cites this paper
• Effects of resistance exercise volume on appetite regulation and lipid profile in overweight young men

  2015cites this paper
• Role of Peptide YY in blood vessel function and atherosclerosis in a rabbit model

  2015cites this paper
• New targets to treat obesity and the metabolic syndrome.

  2015cites this paper
• Gastrointestinal appetite hormones change with maternal adaptations to pregnancy and lactation in the rat

  2015cites this paper
• Investigation of the role of pharmacokinetics and the development of novel anti-obesity agents

  2015influential citation
• MODULAÇÃO DO INFLUXO DE CÁLCIO PELO PEPTÍDEO YY (3-36) EM CÉLULAS DO HIPOCAMPO DE RATOS

  2015cites this paper
• Molecular cloning, expression analysis, and appetite regulatory effect of peptide YY in Siberian sturgeon (Acipenser baerii).

  2015cites this paper
• Effects of acute and chronic exercise on appetite regulatory hormones, craving and body weight in sedentary lean and overweight/obese females

  2015cites this paper
• Decoding insulin resistance and metabolic syndrome for promising therapeutic intervention.

  2014cites this paper
• Hypothalamic and brainstem neuronal circuits controlling homeostatic energy balance.

  2014cites this paper
• The effects of an 8-week supervised exercise program on appetite and appetite-regulating gut hormones in overweight and obese adults

  2014cites this paper
• Historical perspective of peptidomics

  2014cites this paper
• Do glycine-extended hormone precursors have clinical significance?

  2014cites this paper
• Neuroendocrine Mediators, Food Intake and Obesity: A Narrative Review

  2014cites this paper
• Factors affecting circulating levels of peptide YY in humans: a comprehensive review

  2014cites this paper
• Efecto de la sobrenutrición neonatal en la respuesta aguda a la leptina en los periodos prepuberal y peripuberal

  2014cites this paper
• Peptide YY: more than just an appetite regulator

  2014cites this paper
• Physiological Regulation of Short-term Food Intake in Children During Puberty

  2014cites this paper
• Peripher injiziertes sulfatiertes Cholezystokinin-Oktapeptid aktiviert Cocaine- and amphetamine-regulated transcript- immunreaktive Neurone des Nucleus paraventricularis in Ratten

  2014cites this paper
• Secretin: Historical Perspective and Current Status

  2014cites this paper
• The gut-brain axis in obesity.

  2014cites this paper
• Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels.

  2014cites this paper
• Best Practice & Research Clinical Gastroenterology

  2014cites this paper
• SCNH 2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells *

  2013cites this paper
• Investigating the role of gut hormones in energy and glucose homeostasis

  2013cites this paper
• Acute effects of exercise on appetite, food intake and circulating concentrations of gastrointestinal hormones

  2013cites this paper
• Replacement of Thr32 and Gln34 in the C-terminal neuropeptide Y fragment 25-36 by cis-cyclobutane and cis-cyclopentane β-amino acids shifts selectivity toward the Y(4) receptor.

  2013cites this paper
• SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells.

  2013cites this paper
• Pathophysiological aspects of metabolism in patients with inflammatory boweldiseases and patients with liver cirrhosis: relevance for clinical nutrition

  2013cites this paper
• Chapter 157 – PYY

  2013cites this paper
• Las hormonas gastrointestinales en el control de la ingesta

  2013cites this paper
• Oral delivery of therapeutic protein/peptide for diabetes--future perspectives.

  2013cites this paper
• Development of porous silicon nanocarriers for parenteral peptide delivery.

  2013cites this paper
• The Metabolic Effects of Laparoscopic Sleeve Gastrectomy: A Review

  2013cites this paper